$ACST - CaPre Pharmacokinetics Study: $AMRN - Favorable FDA Opinion: $APDN - Successful DNA Tagging: (low float) $BREW - Anheuser-Busch Buyout: $KDMN - Graft-Versus-Host Disease Trial News: $LTS - Merger

$AMRN (AMRN) Amarin stock nice high trade quality setup and move higher off 14.22 double support area, analysis #AMRN

From Motley Fool: Campbell: Amarin markets a drug called Vascepa. Vascepa is a purified omega three fatty acid. We'll call it EPA. It's been on the market since 2012 for use in reducing triglycerides,